Bionomics Appoints Spyridon “Spyros” Papapetropoulos as President and…
ADELAIDE, Australia, December 15, 2022 (GLOBE NEWSWIRE) — Bionomics Limited BNOXBNO)), (Bionomics or the Company), a clinical-stage biopharmaceutical company developing novel allosteric ion channel modulators